Tag: aerie pharmaceuticals

September 19, 2019

Aerie Pharma Seeks FDA Nod to Sell Ireland-based Product in US

If the FDA grants Aerie Pharma approval, it will be able to manufacture Rocklatan in Ireland for sale in the...
August 15, 2018

Aerie Pharmaceuticals Reports Topline Result from Rhopressa Mechanism of Action Study

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...
August 1, 2018

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...
December 20, 2017

Pharma Trends 2017: FDA Pushes Creation of More Generic Drugs

INN takes a look at some of the major stories and developments in the pharma industry during 2017.
October 7, 2016

Q Biomed Comments on its Glaucoma Drug and Industry News in the Ophthalmology Space

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company with a glaucoma drug in development through its partner Mannin Research provides...
September 25, 2016

5 Top NASDAQ Biotech Stocks: Tobira Therapeutics Gains 752 Percent

Last week's top gainer was Tobira Therapeutics, followed by Northwest Biotherapeutics, Sarepta Therapeutics, Novavax and Galectin Therapeutics.
September 18, 2016

5 Top NASDAQ Biotech Stocks: Aerie Pharmaceuticals Up 73 Percent

Last week's top gainer was Aerie Pharmaceuticals, followed by Acasti Pharma, Alphatec Holdings, Northwest Biotherapeutics and Stellar Biotechnologies